Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Drug Repurposing in Oncology : Current Evidence and Future Direction

Zhang, Zhenzhan ; Ji, Jianguang LU orcid and Liu, Hao LU (2020) In Current Medicinal Chemistry 28(11). p.2175-2194
Abstract

BACKGROUND: Drug repurposing, the application of known drugs and compounds with a non-oncology primary purpose, might be an attractive strategy to offer more effective treatment options to patients with cancer at a low cost and reduced time.

METHODS: This review described a total of 10 kinds of non-oncological drugs from more than 100 mechanical studies as well as evidence from population-based studies. The future direction of repurposed drug screening was discussed by using patient-derived tumor organoids.

RESULTS: Many old drugs showed previously unknown effects or off-target effects and can be intelligently applied for cancer chemoprevention and therapy. The identification of repurposed drugs needs to combine evidence... (More)

BACKGROUND: Drug repurposing, the application of known drugs and compounds with a non-oncology primary purpose, might be an attractive strategy to offer more effective treatment options to patients with cancer at a low cost and reduced time.

METHODS: This review described a total of 10 kinds of non-oncological drugs from more than 100 mechanical studies as well as evidence from population-based studies. The future direction of repurposed drug screening was discussed by using patient-derived tumor organoids.

RESULTS: Many old drugs showed previously unknown effects or off-target effects and can be intelligently applied for cancer chemoprevention and therapy. The identification of repurposed drugs needs to combine evidence from mechanical studies and population-based studies. Due to the heterogeneity of cancer, patient-derived tumor organoids can be used to screen the non-oncological drugs in vitro.

CONCLUSION: These identified old drugs could be repurposed in oncology and might be added as adjuvants and finally benefit patients with cancers.

(Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Current Medicinal Chemistry
volume
28
issue
11
pages
2175 - 2194
publisher
Bentham Science Publishers
external identifiers
  • pmid:33109032
  • scopus:85104944304
ISSN
0929-8673
DOI
10.2174/0929867327999200820124111
language
English
LU publication?
yes
id
a45c7fda-0a23-4e14-b760-8ac63bd9ee5e
date added to LUP
2020-11-12 09:22:08
date last changed
2024-06-12 23:44:02
@article{a45c7fda-0a23-4e14-b760-8ac63bd9ee5e,
  abstract     = {{<p>BACKGROUND: Drug repurposing, the application of known drugs and compounds with a non-oncology primary purpose, might be an attractive strategy to offer more effective treatment options to patients with cancer at a low cost and reduced time.</p><p>METHODS: This review described a total of 10 kinds of non-oncological drugs from more than 100 mechanical studies as well as evidence from population-based studies. The future direction of repurposed drug screening was discussed by using patient-derived tumor organoids.</p><p>RESULTS: Many old drugs showed previously unknown effects or off-target effects and can be intelligently applied for cancer chemoprevention and therapy. The identification of repurposed drugs needs to combine evidence from mechanical studies and population-based studies. Due to the heterogeneity of cancer, patient-derived tumor organoids can be used to screen the non-oncological drugs in vitro.</p><p>CONCLUSION: These identified old drugs could be repurposed in oncology and might be added as adjuvants and finally benefit patients with cancers.</p>}},
  author       = {{Zhang, Zhenzhan and Ji, Jianguang and Liu, Hao}},
  issn         = {{0929-8673}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{2175--2194}},
  publisher    = {{Bentham Science Publishers}},
  series       = {{Current Medicinal Chemistry}},
  title        = {{Drug Repurposing in Oncology : Current Evidence and Future Direction}},
  url          = {{http://dx.doi.org/10.2174/0929867327999200820124111}},
  doi          = {{10.2174/0929867327999200820124111}},
  volume       = {{28}},
  year         = {{2020}},
}